-
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic | Morningstar
Источник: Buzz FX / 25 сен 2024 08:00:19 America/New_York
[GlobeNewswire](/news/globe-newswire) Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic Genespire raises €46.6 million (~$52 million) in a Series B round to
Read more...